Bcworldpharm Co (XKRX:200780) Other Financing: ₩-1,442 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:200780 Bcworldpharm Co Ltd XKRX:200780
66 GF Score
Price ₩3,040.00
GF Value ₩5,477.85
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Bcworldpharm Co Other Financing?

Bcworldpharm Co XKRX:200780 +1.00% 66 Other Financing is ₩-1,442 Mil as of Jun. 2026. GuruFocus rates XKRX:200780 with a GF Score™ of 66/100 and a GF Value™ of ₩5,477.85 (Possible Value Trap). The stock has 4 warning signs investors should review.

Bcworldpharm Co's Other Financing for the three months ended in Jun. 2026 was ₩-1,793 Mil.

Bcworldpharm Co's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was ₩-1,442 Mil.

Bcworldpharm Co Other Financing Historical Data

* Premium members only.

The historical data trend for Bcworldpharm Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bcworldpharm Co Other Financing Chart

Bcworldpharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19,892.81 9,880.26 12,760.00 0.00 137.75

Bcworldpharm Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,277.87 1,716.67 -1,332.25 -33.33 -1,793.37
XKRX:200780
66GF Score
Bcworldpharm Co Ltd XKRX:200780
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bcworldpharm Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,442 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ₩-1,442 Mil mean?
Bcworldpharm Co (XKRX:200780) has a Other Financing of ₩-1,442 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Bcworldpharm Co and its competitors.
Is Bcworldpharm Co's Other Financing too high?
Bcworldpharm Co's current Other Financing is ₩-1,442 Mil. Overall, Bcworldpharm Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bcworldpharm Co's Other Financing compare to LLY and JNJ?
Bcworldpharm Co's Other Financing of ₩-1,442 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Bcworldpharm Co and its competitors. Bcworldpharm Co's current Other Financing is ₩-1,442 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bcworldpharm Co stock overvalued right now?
Based on GuruFocus' analysis, Bcworldpharm Co (XKRX:200780) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,477.85, compared to a current price of ₩3,040.00 — trading 44.5% below its estimated fair value. The current Other Financing is ₩-1,442 Mil. Bcworldpharm Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Bcworldpharm Co (XKRX:200780), the current Other Financing is ₩-1,442 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bcworldpharm Co (XKRX:200780) Overvalued in 2026?

Based on GuruFocus' analysis, Bcworldpharm Co stock appears to be undervalued. The current stock price of ₩3,040.00 is trading 44.5% below its estimated GF Value™ of ₩5,477.85. GuruFocus considers Bcworldpharm Co to be Possible Value Trap.

Key valuation signals for XKRX:200780:

  • Other Financing: ₩-1,442 Mil
  • GF Value™: ₩5,477.85 vs. price of ₩3,040.00 (44.5% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the XKRX:200780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bcworldpharm Co Business Description

Address 872-23 Yeoju-nam-ro, Ganam-eup, Gyeonggi-do, Yeoju-si, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The company is engaged in research and develop new and improved drugs through R&D and technological innovation. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics.
66GF Score

Get the complete analysis for XKRX:200780

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩3,040.00
Price
₩5,477.85
GF Value